The Essential Medicinal Chemistry of Curcumin
Open accessThe DOI matches its Crossref record; 151 of the 153 references it cites were found in a registry or an index.
Abstract
Curcumin is a constituent (up to ∼5%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double-blinded, placebo controlled clinical trial of curcumin has been successful. This manuscript reviews the essential medicinal chemistry of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead. On the basis of this in-depth evaluation, potential new directions for research on curcuminoids are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One mechanism by which polyphenols could exert protective properties is by generation of a hormetic response to their use85–88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In vivo use of polyphenols (especially curcumin) in some mouse models of AD has been successful77,87, but this has not (yet) been translated to usefulness in human AD2,70,87,88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Tomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Takasu, N., Matsuda, T., Ohta, T., Tanaka, Y., & Mori, N. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.08.004 · Cited by 55
RetractedKundu, P., Mohanty, C., & Sahoo, S. K. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.048 · Cited by 51
RetractedDilnawaz, F., Singh, A., & Sahoo, S. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.10.022 · Cited by 33
RetractedSeely, K. A., Levi, M. S., & Prather, P. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151654 · Cited by 21
RetractedNi, Z., Xing, F., Wang, P., & Cao, G. (2007) · Applied Clay Science · doi:10.1016/j.clay.2007.07.008 · Cited by 20
RetractedPrather, P. L., Seely, K. A., & Levi, M. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)45583-3 · Cited by 3
RetractedGlutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“136 However, the extremely long incubation times reported here would require follow-up to exclude the likely possibility of aggregation or degradation in the assay conditions.”
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Research works printed but not linked: 4
- 2. Hanson M. Is the 2015 Nobel Prize a turning point for traditional Chinese medicine? https://theconversation.com/is-the-2015-nobel-prize-a-turning-point-for-traditional-chinese-medicine-48643 (accessed June 6, 2016). · DOI
- 10. Elias G.; Jacob P. J.; Hareeshbabu E.; Mathew V. B.; Krishnan B.; Krishnakumar K. Curcumin: Transforming the spice to a wonder drug. Int. J. Pharm. Sci. Res. 2015, 6, 2671– 2680. 10.13040/IJPSR.0975-8232.6(7).2671-80. · doi:10.13040/ijpsr.0975-8232.6(7).2671-80
- 35. Majeed S. The state of the curcumin market. Natural Products Insider; Informa Exhibitions, 2015; http://www.naturalproductsinsider.com/articles/2015/12/the-state-of-the-curcumin-market.aspx.
- 36. Niranjan A.; Prakash D. Chemical constituents and biological activities of turmeric (Curcuma longa l.) - a review. J. Food Sci. Technol. (New Delhi, India) 2008, 45, 109– 116.
Cited by
Items 1,001–1,003 of 1,003
Sakamuru, S., Huang, R., & Xia, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935399 · Cited by 11
“However, curcumin and its analogues appear to be challenging due to the lack of chemical stability, solubility, selective target activity and bioavailability and had been classified as a pan-assay interference compound (PAIN), and therefore it is an improbable lead (Nelson et al., 2017).”
Background1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
Ortíz de Zárate, A., Pérez-Torralba, M., Bonet Isidro, I., López, C., Claramunt, R. M., Martínez-Casanova, D., Sánchez-Vera, I., Jiménez-González, J., & Lavandera, J. L. (2021) · Antioxidants · doi:10.3390/antiox10101584 · Cited by 11
Mödlhammer, A., Pfurtscheller, S., Feichtner, A., Hartl, M., & Schneider, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.660481 · Cited by 7
“However, as mentioned above the major obstacle in the usage of curcumin is its low bioavailability due to the high hydrophobicity (23).”
Background
Metadata
- Authors
- Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A.
- Affiliations
- University of Minnesota (US)
- Brigham and Women's Hospital (US)
- University of Illinois Chicago (US)
- Corresponding author
- Walters, Michael A.
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-01-11
- Volume
- 60
- Issue
- 5
- Pages
- 1620-1637
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5346970
- OpenAlex
- W2579340176
- Cited by
- 1,956
- References
- 153
- Citations by year
- 2026: 177 · 2025: 213 · 2024: 204 · 2023: 233 · 2022: 244 · 2021: 257 · 2020: 211 · 2019: 183 · 2018: 157 · 2017: 75
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- University of Illinois Chicago
- Funders
- Office of Dietary Supplements (U41AT008706)
- National Center for Complementary and Integrative Health (U41AT008706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Saffron Plant Research Studies
- Keywords
- curcumin, curcuminoids, turmeric, medicinal chemistry, PAINS, IMPS, bioavailability, clinical trials
- MeSH terms
- Animals, Chemistry, Pharmaceutical, Curcumin, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.